Tracon Pharmaceuticals, Inc. Business Operations Contracts & Agreements
10 Contracts & Agreements
- Collaboration Agreements (1 contract)
- Development Agreements (7)
- Sales Agreements (2)
- Collaborative Development and Commercialization Agreement by and among the Registrant, Eucure (Beijing) Biopharma Co., Ltd. and Biocytogen Pharmaceuticals (Beijing) Co., Ltd.... (Filed With SEC on November 3, 2021)
- Amendment #2 to Cooperative Research and Development Agreement by and between the Registrant and the U.S. Department of Health and Human Services, as represented by National... (Filed With SEC on February 25, 2021)
- Collaboration and Clinical Trial Agreement by and among the Registrant, 3D Medicines (Beijing) Co., LTD. and Jiangsu Alphamab Biopharmaceuticals Co., LTD. dated December 20, 2019 (Filed With SEC on February 28, 2020)
- Amendment No. 1 to Capital on DemandTM Sales Agreement, dated as of February 28, 2019, by and between the Registrant and JonesTrading Institutional Services LLC (Filed With SEC on November 5, 2019)
- PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR INTRAMURAL-PHS CLINICAL RESEARCH (Filed With SEC on December 29, 2014)
- PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR EXTRAMURAL-PHS CLINICAL RESEARCH (Filed With SEC on December 29, 2014)
- LICENCE AGREEMENT between LONZA SALES AG and TRACON PHARMACEUTICALS INC (Filed With SEC on December 29, 2014)
- Amendment #2 Cooperative Research and Development Agreement #02661 “Development of the Human Chimeric Monoclonal Antibody TRC105, an Angiogenesis Inhibitor Provided by Tracon... (Filed With SEC on February 19, 2016)
- AMENDMENT #2 Cooperative Research and Development Agreement #02663 “Clinical Development of Tracon Pharmaceuticals Inc.’s TRC105, an anti-CD105 antibody, as an Anti-Cancer... (Filed With SEC on February 19, 2016)
- PUBLIC HEALTH SERVICE COOPERATIVE RESEARCH AND DEVELOPMENT AGREEMENT FOR NCI DIVISION OF CANCER TREATMENT AND DIAGNOSIS (DCTD) EXTRAMURAL PHS CLINICAL RESEARCH (Filed With SEC on December 29, 2014)
